Antibodies against sporothrix schenckii enhance TNF-α production and killing by macrophages

Scandinavian Journal of Immunology

Volumn 75, Issue 2, 2012, Pages 142-146

  de Lima Franco, D ^a   Nascimento, R C ^a,b   Ferreira, K S ^c   Almeida, S R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FUNGUS ANTIBODY; INTERLEUKIN 1BETA; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA; ANTISERUM; OPSONIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ASSAY; CELL KILLING; CELLULAR IMMUNITY; COLONY FORMING UNIT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FUNGICIDAL ACTIVITY; HOST RESISTANCE; IMMUNE RESPONSE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; SPOROTHRIX SCHENCKII; SPOROTRICHOSIS; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; ISOLATION AND PURIFICATION; MACROPHAGE; MICROBIAL VIABILITY; MICROBIOLOGY; PATHOLOGY; SPOROTHRIX;

ANIMALS; ANTIBODIES, FUNGAL; CELL LINE; FEMALE; IMMUNE SERA; IMMUNITY, CELLULAR; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROBIAL VIABILITY; OPSONIN PROTEINS; PHAGOCYTOSIS; SPOROTHRIX; SPOROTRICHOSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855725688     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2011.02636.x     Document Type: Article

References (25)

1. Belknap BS. Sporotrichosis. Dermatol Clin 1989;7:193-202.
2. Gutierrez-Galhardo MC, do Valle AC, Fraga BL et al. Disseminated sporotrichosis as a manifestation of immune reconstitution inflammatory syndrome. Mycoses 2010;53:78-80.
3. Fontes PC, Kitakawa D, Carvalho YR, Brandao AA, Cabral LA, Almeida JD. Sporotrichosis in an HIV-positive man with oral lesions: a case report. Acta Cytol 2007;51:648-50.
4. Carlos IZ, Sassa MF, da Graca Sgarbi DB, Placeres MC, Maia DC. Current research on the immune response to experimental sporotrichosis. Mycopathologia 2009;168:1-10.
5. Shiraishi A, Nakagaki K, Arai T. Role of cell-mediated immunity in the resistance to experimental sporotrichosis in mice. Mycopathologia 1992;120:15-21.
6. Tachibana T, Matsuyama T, Mitsuyama M. Involvement of CD4+ T cells and macrophages in acquired protection against infection with Sporothrix schenckii in mice. Med Mycol 1999;37:397-404.
7. Khardori N. Host-parasite interaction in fungal infections. Eur J Clin Microbiol Infect Dis 1989;8:331-51.
8. Wozniak KL, Ravi S, Macias S et al. Insights into the mechanisms of protective immunity against Cryptococcus neoformans infection using a mouse model of pulmonary cryptococcosis. PLoS ONE 2009;4:e6854.
9. Casadevall A, Pirofski LA. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv Immunol 2006;91:1-44.
10. Torosantucci A, Chiani P, Bromuro C et al. Protection by anti-beta-glucan antibodies is associated with restricted beta-1, 3 glucan binding specificity and inhibition of fungal growth and adherence. PLoS ONE 2009;4:e5392.
11. Nascimento RC, Almeida SR. Humoral immune response against soluble and fractionate antigens in experimental sporotrichosis. FEMS Immunol Med Microbiol 2005;43:241-7.
12. Nascimento RC, Espindola NM, Castro RA et al. Passive immunization with monoclonal antibody against a 70-kDa putative adhesin of Sporothrix schenckii induces protection in murine sporotrichosis. Eur J Immunol 2008;38:3080-9.
13. Oda LM, Kubelka CF, Alviano CS, Travassos LR. Ingestion of yeast forms of Sporothrix schenckii by mouse peritoneal macrophages. Infect Immun 1983;39:497-504.
14. Casadevall A, Pirofski L. Insights into mechanisms of antibody-mediated immunity from studies with Cryptococcus neoformans. Curr Mol Med 2005;5:421-33.
15. Alvarez M, Saylor C, Casadevall A. Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation. Cell Microbiol 2008;10:1622-33.
16. Richards JO, Karki S, Lazar GA, Chen H, Dang W, Desjarlais JR. Optimization of antibody binding to FcgammaRIIa enhances macrophage phagocytosis of tumor cells. Mol Cancer Ther 2008;7:2517-27.
17. Clavel C, Nogueira L, Laurent L et al. Induction of macrophage secretion of tumor necrosis factor alpha through Fcgamma receptor IIa engagement by rheumatoid arthritis-specific autoantibodies to citrullinated proteins complexed with fibrinogen. Arthritis Rheum 2008;58:678-88.
18. Caron E, Hall A. Identification of two distinct mechanisms of phagocytosis controlled by different Rho GTPases. Science 1998;282:1717-21.
19. Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002;20:825-52.
20. Zhang J, Tachado SD, Patel N et al. Negative regulatory role of mannose receptors on human alveolar macrophage proinflammatory cytokine release in vitro. J Leukoc Biol 2005;78:665-74.
21. Garcia-Garcia E, Rosales C. Signal transduction during Fc receptor-mediated phagocytosis. J Leukoc Biol 2002;72:1092-108.
22. Wijngaarden S, van de Winkel JG, Bijlsma JW, Lafeber FP, van Roon JA. Treatment of rheumatoid arthritis patients with anti-TNF-alpha monoclonal antibody is accompanied by down-regulation of the activating Fcgamma receptor I on monocytes. Clin Exp Rheumatol 2008;26:89-95.
23. Carlos IZ, Sgarbi DB, Santos GC, Placeres MC. Sporothrix schenckii lipid inhibits macrophage phagocytosis: involvement of nitric oxide and tumour necrosis factor-alpha. Scand J Immunol 2003;57:214-20.
24. Carlos IZ, Zini MM, Sgarbi DB, Angluster J, Alviano CS, Silva CL. Disturbances in the production of interleukin-1 and tumor necrosis factor in disseminated murine sporotrichosis. Mycopathologia 1994;127:189-94.
25. Gottlieb GS, Lesser CF, Holmes KK, Wald A. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Clin Infect Dis 2003;37:838-40.